|
聚丙烯酸叔丁酯
|
P767844-180kDa-25g
|
|
25232-27-3 |
25g
|
¥ 1749.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
聚丙烯酸叔丁酯
|
P767844-180kDa-1g
|
|
25232-27-3 |
1g
|
¥ 100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4-吡啶基-4-苯基)甲醇
|
P701284-50mg
|
≥95% |
217192-22-8 |
50mg
|
¥ 129.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
吡嗪-2,5-二胺
|
P700550-5g
|
≥97% |
768386-37-4 |
5g
|
¥ 2347.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1,3,3,3-六氟-2-(4-羟基苯基)丙-2-醇
|
P698150-5g
|
≥98% |
836-79-3 |
5g
|
¥ 2199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1,3,3,3-六氟-2-(4-羟基苯基)丙-2-醇
|
P698150-250mg
|
≥98% |
836-79-3 |
250mg
|
¥ 229.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1,1,3,3,3-六氟-2-(4-羟基苯基)丙-2-醇
|
P698150-1g
|
≥98% |
836-79-3 |
1g
|
¥ 549.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
芘-4,5-二酮
|
P696056-50mg
|
≥95% |
6217-22-7 |
50mg
|
¥ 169.9
|
现货 |
|
0 |
阿拉丁 |
|
2-(羟甲基)异烟酸
|
P680589-50mg
|
≥97% |
915140-06-6 |
50mg
|
¥ 389.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(三氟甲基)嘧啶-4,6-二醇
|
P638337-5g
|
≥97% |
672-47-9 |
5g
|
¥ 899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(三氟甲基)嘧啶-4,6-二醇
|
P638337-50mg
|
≥97% |
672-47-9 |
50mg
|
¥ 42.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(三氟甲基)嘧啶-4,6-二醇
|
P638337-250mg
|
≥97% |
672-47-9 |
250mg
|
¥ 99.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(4-羟基苯基)-2-氧代乙酸
|
O693308-50mg
|
≥95% |
15573-67-8 |
50mg
|
¥ 259.9
|
现货 |
|
0 |
阿拉丁 |
|
2-(4-羟基苯基)-2-氧代乙酸
|
O693308-250mg
|
≥95% |
15573-67-8 |
250mg
|
¥ 899.9
|
现货 |
|
0 |
阿拉丁 |
|
2-(4-羟基苯基)-2-氧代乙酸
|
O693308-1g
|
≥95% |
15573-67-8 |
1g
|
¥ 2199.9
|
现货 |
|
0 |
阿拉丁 |
|
4-氧代-3,4-二氢酞嗪-1-羧酸
|
O638206-50mg
|
≥96% |
3260-44-4 |
50mg
|
¥ 99.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-氧代-3,4-二氢酞嗪-1-羧酸
|
O638206-250mg
|
≥96% |
3260-44-4 |
250mg
|
¥ 369.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
全氟丁基磺酰氯
|
N777397-5g
|
≥99% |
2991-84-6 |
5g
|
¥ 1049.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
全氟丁基磺酰氯
|
N777397-25g
|
≥99% |
2991-84-6 |
25g
|
¥ 2519.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
全氟丁基磺酰氯
|
N777397-1g
|
≥99% |
2991-84-6 |
1g
|
¥ 419.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-甲基间苯二胺
|
N709481-5g
|
≥95% |
50617-73-7 |
5g
|
¥ 1699.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-对甲苯磺酰甲基甲酰胺
|
N698019-250mg
|
≥95% |
36635-56-0 |
250mg
|
¥ 269.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-([1,1'-联苯]-4-基)-N-(吡啶-2-基)乙酰胺
|
N695367-50mg
|
Moligand™, ≥97% |
51484-40-3 |
50mg
|
¥ 180.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-([1,1'-联苯]-4-基)-N-(吡啶-2-基)乙酰胺
|
N695367-250mg
|
Moligand™, ≥97% |
51484-40-3 |
250mg
|
¥ 545.9
|
期货,请咨询 |
|
0 |
阿拉丁 |